| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.31 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |